Northeast Financial Consultants’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.95M | Sell |
79,059
-4,831
| -6% | -$303K | 0.2% | 65 |
|
2025
Q1 | $5.05M | Sell |
83,890
-21,557
| -20% | -$1.3M | 0.22% | 60 |
|
2024
Q4 | $6.15M | Sell |
105,447
-24,339
| -19% | -$1.42M | 0.26% | 54 |
|
2024
Q3 | $7.69M | Sell |
129,786
-8,915
| -6% | -$528K | 0.34% | 51 |
|
2024
Q2 | $7.77M | Sell |
138,701
-20,388
| -13% | -$1.14M | 0.36% | 46 |
|
2024
Q1 | $9.32M | Sell |
159,089
-49,637
| -24% | -$2.91M | 0.46% | 37 |
|
2023
Q4 | $11.3M | Sell |
208,726
-21,450
| -9% | -$1.16M | 0.62% | 27 |
|
2023
Q3 | $11.2M | Sell |
230,176
-7,729
| -3% | -$375K | 0.7% | 24 |
|
2023
Q2 | $13.4M | Sell |
237,905
-2,155
| -0.9% | -$122K | 0.82% | 23 |
|
2023
Q1 | $13M | Sell |
240,060
-32,980
| -12% | -$1.78M | 0.83% | 23 |
|
2022
Q4 | $14.4M | Sell |
273,040
-87,527
| -24% | -$4.6M | 0.97% | 21 |
|
2022
Q3 | $17M | Sell |
360,567
-47,941
| -12% | -$2.26M | 1.25% | 18 |
|
2022
Q2 | $20.6M | Sell |
408,508
-40,301
| -9% | -$2.03M | 1.44% | 15 |
|
2022
Q1 | $27.4M | Buy |
448,809
+49,290
| +12% | +$3M | 1.58% | 12 |
|
2021
Q4 | $26.3M | Buy |
399,519
+91,210
| +30% | +$6.01M | 1.59% | 13 |
|
2021
Q3 | $19.4M | Buy |
308,309
+74,297
| +32% | +$4.66M | 1.29% | 19 |
|
2021
Q2 | $14.1M | Buy |
234,012
+49,218
| +27% | +$2.96M | 0.95% | 24 |
|
2021
Q1 | $10.2M | Buy |
184,794
+34,584
| +23% | +$1.9M | 0.78% | 28 |
|
2020
Q4 | $8.19M | Buy |
150,210
+66,888
| +80% | +$3.65M | 0.68% | 30 |
|
2020
Q3 | $4.16M | Buy |
83,322
+1,308
| +2% | +$65.3K | 0.38% | 44 |
|
2020
Q2 | $3.62M | Buy |
82,014
+51,234
| +166% | +$2.26M | 0.35% | 44 |
|
2020
Q1 | $1.16M | Buy |
30,780
+9,066
| +42% | +$340K | 0.13% | 99 |
|
2019
Q4 | $957K | Buy |
21,714
+5,244
| +32% | +$231K | 0.09% | 138 |
|
2019
Q3 | $678K | Buy |
16,470
+5,508
| +50% | +$227K | 0.07% | 161 |
|
2019
Q2 | $440K | Buy |
10,962
+4,584
| +72% | +$184K | 0.05% | 194 |
|
2019
Q1 | $246K | Buy |
+6,378
| New | +$246K | 0.03% | 266 |
|